|
Index of reports
> Cases resulting in disability (45)
> Cases with Headache (7)
Below is the selection of adverse event reports related to Singulair (Montelukast) that includes cases resulting in disability where reactions include headache.
Adverse event in 8 year old female receiving Singulair (Montelukast)
Reported by a consumer/non-health professional from United States on 2007-10-04
Patient: 8 year old female
Adverse reactions / side effects: Vomiting, Headache
Adverse event resulted in: disablity
Suspect drug(s):
Advair Diskus 100 / 50
Dosage: 2puff twice per day
Indication: Asthma
Start date: 2007-01-01
Singulair
Dosage: 5mg per day
Administration route: Oral
Indication: Asthma
Start date: 2005-01-01
End date: 2007-06-01
Other drugs received by patient: Spiriva; Zyrtec; Intal; Albuterol
Adverse event in 6 year old male receiving Singulair (Montelukast)
Reported by a consumer/non-health professional from United States on 2007-07-26
Patient: 6 year old male, weighing 29.0 kg (63.8 pounds)
Adverse reactions / side effects: Hallucination, Auditory, Dyskinesia, Abasia, Headache, Constipation, Feeling Cold, Malaise, Fatigue, Anger, Aura, Migraine, Nightmare, Clonus, Muscular Weakness, Flushing, Arthralgia, Hallucination, Visual, Diarrhoea, Ear Pain, Parosmia, Complex Partial Seizures, Athetosis
Adverse event resulted in: hospitalization, disablity
Suspect drug(s):
Singulair (Montelukast)
Other drugs received by patient: Albuterol
Adverse event in 36 year old female receiving Singulair (Montelukast)
Reported by a physician from Norway on 2007-06-08
Patient: 36 year old female
Adverse reactions / side effects: Listless, Joint Swelling, Nausea, Oedema Peripheral, Dizziness, Headache, Pyrexia
Adverse event resulted in: disablity
Suspect drug(s):
Singulair
Administration route: Oral
Indication: Asthma
Start date: 2007-02-01
End date: 2007-04-20
Singulair
Administration route: Oral
Indication: Rhinitis Allergic
Start date: 2007-02-01
End date: 2007-04-20
Adverse event in 65 year old female receiving Singulair (Montelukast)
Reported by a physician from Poland on 2007-05-15
Patient: 65 year old female, weighing 86.0 kg (189.2 pounds)
Adverse reactions / side effects: Abdominal Pain, Movement Disorder, Pruritus, Bone Pain, Petechiae, Cerebrovascular Disorder, Headache, Somnolence, Generalised Oedema, Hypercholesterolaemia, Myalgia, Fatigue, Face Oedema, Chest Pain, DRY Mouth, Conjunctival Hyperaemia, Oedema Peripheral, Abdominal Distension, Dizziness, Depression, Acute Coronary Syndrome, Cough, Muscle Spasms, Back Pain, Dyspnoea, Autonomic Nervous System Imbalance, Nausea, Hypotension, Rash, Skin Tightness, Anxiety, Syncope, Arthralgia, Feeling Abnormal
Adverse event resulted in: life threatening event, hospitalization, disablity
Suspect drug(s):
Singulair
Administration route: Oral
Indication: Rhinitis Allergic
Start date: 2004-11-01
End date: 2006-06-01
Singulair
Administration route: Oral
Indication: Asthma
Start date: 2004-11-01
End date: 2006-06-01
Other drugs received by patient: Levothyroxine Sodium; Quinapril Hydrochloride; Quinapril Hydrochloride; Ticlopidine Hydrochloride; Amlodipine Besylate; Amlodipine Besylate; Amlodipine Besylate; Amlodipine Besylate; Ranitidine; Simvastatin; Simvastatin; Nicergoline; Perazine Dimalonate; Aspirin; Aspirin; Imipramine Hydrochloride; Metoprolol; Isosorbide Dinitrate; Simvastatin; Chlorthalidone; Prednisone; Loratadine; Fluvoxamine Maleate; Modafinil
Adverse event in 65 year old female receiving Singulair (Montelukast)
Reported by a physician from Poland on 2007-05-11
Patient: 65 year old female, weighing 86.0 kg (189.2 pounds)
Adverse reactions / side effects: Abdominal Pain, Movement Disorder, Pruritus, Bone Pain, Petechiae, Cerebrovascular Disorder, Headache, Somnolence, Generalised Oedema, Hypercholesterolaemia, Myalgia, Fatigue, Face Oedema, Chest Pain, DRY Mouth, Conjunctival Hyperaemia, Oedema Peripheral, Abdominal Distension, Dizziness, Depression, Acute Coronary Syndrome, Cough, Muscle Spasms, Back Pain, Dyspnoea, Autonomic Nervous System Imbalance, Nausea, Hypotension, Rash, Skin Tightness, Anxiety, Arthralgia, Feeling Abnormal
Adverse event resulted in: life threatening event, hospitalization, disablity
Suspect drug(s):
Singulair
Administration route: Oral
Indication: Rhinitis Allergic
Start date: 2004-11-01
End date: 2006-06-01
Singulair
Administration route: Oral
Indication: Asthma
Start date: 2004-11-01
End date: 2006-06-01
Other drugs received by patient: Levothyroxine Sodium; Quinapril Hydrochloride; Quinapril Hydrochloride; Ticlopidine Hydrochloride; Amlodipine Besylate; Amlodipine Besylate; Amlodipine Besylate; Amlodipine Besylate; Ranitidine; Simvastatin; Simvastatin; Nicergoline; Perazine Dimalonate; Aspirin; Aspirin; Imipramine Hydrochloride; Metoprolol; Isosorbide Dinitrate; Simvastatin; Chlorthalidone; Prednisone; Loratadine; Fluvoxamine Maleate; Modafinil
Adverse event in 65 year old female receiving Singulair (Montelukast)
Reported by a physician from Poland on 2007-02-20
Patient: 65 year old female, weighing 86.0 kg (189.2 pounds)
Adverse reactions / side effects: Abdominal Pain, Movement Disorder, Pruritus, Bone Pain, Petechiae, Cerebrovascular Disorder, Headache, Somnolence, Generalised Oedema, Hypercholesterolaemia, Myalgia, Fatigue, Face Oedema, Chest Pain, DRY Mouth, Conjunctival Hyperaemia, Oedema Peripheral, Abdominal Distension, Dizziness, Depression, Acute Coronary Syndrome, Cough, Muscle Spasms, Back Pain, Dyspnoea, Autonomic Nervous System Imbalance, Nausea, Hypotension, Rash, Skin Tightness, Anxiety, Arthralgia, Feeling Abnormal
Adverse event resulted in: life threatening event, hospitalization, disablity
Suspect drug(s):
Singulair
Administration route: Oral
Indication: Rhinitis Allergic
Start date: 2004-11-01
End date: 2006-06-01
Singulair
Administration route: Oral
Indication: Asthma
Start date: 2004-11-01
End date: 2006-06-01
Other drugs received by patient: Levothyroxine Sodium; Quinapril Hydrochloride; Quinapril Hydrochloride; Ticlopidine Hydrochloride; Amlodipine Besylate; Amlodipine Besylate; Amlodipine Besylate; Amlodipine Besylate; Ranitidine; Simvastatin; Simvastatin; Nicergoline; Perazine Dimalonate; Aspirin; Aspirin; Imipramine Hydrochloride; Metoprolol; Isosorbide Dinitrate; Simvastatin; Chlorthalidone; Prednisone; Loratadine; Fluvoxamine Maleate; Modafinil
Adverse event in 65 year old female receiving Singulair (Montelukast)
Reported by a physician from Poland on 2007-02-19
Patient: 65 year old female, weighing 86.0 kg (189.2 pounds)
Adverse reactions / side effects: Abdominal Pain, Movement Disorder, Pruritus, Bone Pain, Petechiae, Cerebrovascular Disorder, Headache, Somnolence, Generalised Oedema, Myalgia, Face Oedema, Fatigue, DRY Mouth, Chest Pain, Conjunctival Hyperaemia, Oedema Peripheral, Abdominal Distension, Dizziness, Depression, Acute Coronary Syndrome, Cough, Muscle Spasms, Back Pain, Dyspnoea, Nausea, Hypotension, Rash, Skin Tightness, Anxiety, Arthralgia, Feeling Abnormal
Adverse event resulted in: life threatening event, hospitalization, disablity
Suspect drug(s):
Singulair
Administration route: Oral
Indication: Rhinitis Allergic
Start date: 2004-11-01
End date: 2006-06-01
Singulair
Administration route: Oral
Indication: Asthma
Start date: 2004-11-01
End date: 2006-06-01
Other drugs received by patient: Levothyroxine Sodium; Quinapril Hydrochloride; Quinapril Hydrochloride; Ticlopidine Hydrochloride; Amlodipine Besylate; Amlodipine Besylate; Amlodipine Besylate; Amlodipine Besylate; Ranitidine; Simvastatin; Simvastatin; Nicergoline; Perazine Dimalonate; Aspirin; Aspirin; Imipramine Hydrochloride; Metoprolol; Isosorbide Dinitrate; Simvastatin; Chlorthalidone; Prednisone; Loratadine; Fluvoxamine Maleate; Modafinil
|
